Table 1.
Demographic Characteristics of Participants (n = 216)
Characteristics | Values |
---|---|
Gender, n (%) | |
Males | 118 (54.6%) |
Females | 98 (45.4%) |
Age, Mean (SD) in years | 41.76 (12.83) |
Education, n (%) | |
≤6 years | 59 (27.31%) |
6-12 years | 117 (54.67%) |
>12 years | 40 (18.52%) |
Treatment, mg, Median (Range) | |
Aripiprazole (n = 11) | 20 (15-30) |
Olanzapine (n = 107) | 20 (10-30) |
Quetiapine (n = 27) | 700 (300-750) |
Risperidone (n = 36) | 5 (4-6) |
Clozapine (n = 35) | 400 (250-400) |
Sum scores of PANSS-30, Mean (SD) | |
Baseline | 94.82±10.93 |
Week 4 | 74.07±16.53 |
Week 8 | 64.19±13.89 |
Sum scores of PANSS-6, Mean (SD) | |
Baseline | 23.96±3.72 |
Week 4 | 18.65±4.58 |
Week 8 | 15.55±4.07 |